One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Increasing diversity in dementia research
doi : 10.1016/S1474-4422(22)00487-2
Volume 22, Issue 1, January 2023, Page 1
Credulity of exploratory trials for cerebral cavernous malformations
Robert Shenkar, *Issam A Awad
doi : 10.1016/S1474-4422(22)00440-9
Volume 22, Issue 1, January 2023, Pages 2-3
Early atrial fibrillation rhythm control after stroke
Peter Calvert, Dhiraj Gupta, *Gregory Y H Lip
doi : 10.1016/S1474-4422(22)00470-7
Volume 22, Issue 1, January 2023, Pages 3-4
Lessons from Down syndrome and autosomal dominant Alzheimer's disease
*Juan Fortea, Yakeel T Quiroz, Natalie S Ryan
doi : 10.1016/S1474-4422(22)00437-9
Volume 22, Issue 1, January 2023, Pages 5-6
Time to reconsider the classification of multiple sclerosis
Takashi Yamamura
doi : 10.1016/S1474-4422(22)00469-0
Volume 22, Issue 1, January 2023, Pages 6-8
Clinical trials in stroke in 2022: new answers and questions
*Mayank Goyal, Nishita Singh, Johanna Ospel
doi : 10.1016/S1474-4422(22)00488-4
Volume 22, Issue 1, January 2023, Pages 9-10
Dementia research in 2022: advancing steadily on reflection
Ya-Ru Zhang, Kevin Kuo, Qiang Dong, *Jin-Tai Yu
doi : 10.1016/S1474-4422(22)00473-2
Volume 22, Issue 1, January 2023, Pages 10-12
Highlights in traumatic brain injury research in 2022
Chiara Robba, *Giuseppe Citerio
doi : 10.1016/S1474-4422(22)00472-0
Volume 22, Issue 1, January 2023, Pages 12-13
Headache research in 2022: advances and remaining challenges
Uwe Reuter
doi : 10.1016/S1474-4422(22)00489-6
Volume 22, Issue 1, January 2023, Pages 14-15
Epilepsy research in 2022: clinical advances
Leah J Blank, *Nathalie Jette
doi : 10.1016/S1474-4422(22)00486-0
Volume 22, Issue 1, January 2023, Pages 15-17
Research in movement disorders in 2022: a new era of biomarker and treatment development
*Christine Klein, Bastiaan R Bloem
doi : 10.1016/S1474-4422(22)00494-X
Volume 22, Issue 1, January 2023, Pages 17-19
Multiple sclerosis in 2022: old players, new insights
Tanuja Chitnis
doi : 10.1016/S1474-4422(22)00479-3
Volume 22, Issue 1, January 2023, Pages 19-21
Advances in amyotrophic lateral sclerosis research in 2022
Mamede de Carvalho
doi : 10.1016/S1474-4422(22)00490-2
Volume 22, Issue 1, January 2023, Pages 21-22
Ideas that come at night: on sleep research in 2022
Isabelle Arnulf
doi : 10.1016/S1474-4422(22)00481-1
Volume 22, Issue 1, January 2023, Pages 23-24
Pain research in 2022: nociceptors and central sensitisation
Rolf-Detlef Treede
doi : 10.1016/S1474-4422(22)00485-9
Volume 22, Issue 1, January 2023, Pages 24-25
Neuroscience highlights in 2022: cytoskeletal transport
*James N Sleigh, Giampietro Schiavo
doi : 10.1016/S1474-4422(22)00482-3
Volume 22, Issue 1, January 2023, Pages 25-27
The shortage of thrombolytics for stroke: a call for action
Umberto Pensato, Michele Romoli, Serena Marita Lazzarin, Simona Marcheselli, Andrea Zini
doi : 10.1016/S1474-4422(22)00477-X
Volume 22, Issue 1, January 2023, Page 28
The African Dementia Consortium
Rufus O Akinyemi, Mayowa O Owolabi, Njideka Okubadejo, Adesola Ogunniyi, *Raj N Kalaria, on behalf of the African Dementia Consortium
doi : 10.1016/S1474-4422(22)00475-6
Volume 22, Issue 1, January 2023, Pages 28-29
Bastiaan Bloem: power against Parkinson's disease
Adrian Burton
doi : 10.1016/S1474-4422(22)00393-3
Volume 22, Issue 1, January 2023, Page 30
The advent of stroke units
Emmanuel Drouin, Marta Pasquini, Patrick Hautecoeur
doi : 10.1016/S1474-4422(22)00491-4
Volume 22, Issue 1, January 2023, Page 31
Studying sex and gender in neurological disease
Linda Al-Hassany, Petra Verdonk,
doi : 10.1016/S1474-4422(22)00493-8
Volume 22, Issue 1, January 2023, Pages 32-33
Neurology behind the lens
Rui Araújo
doi : 10.1016/S1474-4422(22)00310-6
Volume 22, Issue 1, January 2023, Page 34
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
Silvia Lanfranconi, Elisa Scola, Jennifer M T A Meessen, Roberto Pallini, Giulio A Bertani, Rustam Al-Shahi Salman, Elisabetta Dejana, Roberto Latini, on behalf of the Treat_CCM Investigators
doi : 10.1016/S1474-4422(22)00409-4
Volume 22, Issue 1, January 2023, Pages 35-44
Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial
Märit Jensen, Anna Suling, Andreas Metzner, Renate B Schnabel, Katrin Borof, Andreas Goette, Karl Georg Haeusler, Antonia Zapf, Karl Wegscheider, Larissa Fabritz, Hans-Christoph Diener, Götz Thomalla, Paulus Kirchhof
doi : 10.1016/S1474-4422(22)00436-7
Volume 22, Issue 1, January 2023, Pages 45-54
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study
Anna H Boerwinkle, Brian A Gordon, Julie Wisch, Shaney Flores, Rachel L Henson, Omar H Butt, Nicole McKay, Charles D Chen, Tammie L S Benzinger, Anne M Fagan, Benjamin L Handen, Bradley T Christian, Elizabeth Head, Mark Mapstone, Michael S Rafii, Sid O’Bryant, Florence Lai, H Diana Rosas, Joseph H Lee, Wayne Silverman, Adam M Brickman, Jasmeer P Chhatwal, Carlos Cruchaga, Richard J Perrin, Chengjie Xiong, Jason Hassenstab, Eric McDade, Randall J Bateman, Beau M Ances, on behalf of the Alzheimer’s Biomarker Consortium-Down Syndrome* and the Dominantly Inherited Alzheimer Network*
doi : 10.1016/S1474-4422(22)00408-2
Volume 22, Issue 1, January 2023, Pages 55-65
Ageing and multiple sclerosis
Jennifer S Graves, Kristen M Krysko, Le H Hua, Martina Absinta, Robin J M Franklin, Benjamin M Segal
doi : 10.1016/S1474-4422(22)00184-3
Volume 22, Issue 1, January 2023, Pages 66-77
Multiple sclerosis progression: time for a new mechanism-driven framework
Tanja Kuhlmann, Marcello Moccia, Timothy Coetzee*, Jeffrey A Cohen*, Jorge Correale*, Jennifer Graves, Ruth Ann Marrie*, Xavier Montalban*, V Wee Yong, Alan J Thompson,* Daniel S Reich,* on behalf of the International Advisory Committee on Clinical Trials in Multiple Sclerosisâ€
doi : 10.1016/S1474-4422(22)00289-7
Volume 22, Issue 1, January 2023, Pages 78-88
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment
Jeffrey L Bennett, Fiona Costello, John J Chen, Axel Petzold, Valérie Biousse, Nancy J Newman, Steven L Galetta
doi : 10.1016/S1474-4422(22)00187-9
Volume 22, Issue 1, January 2023, Pages 89-100
